• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

aetna

  1. CVS Health swings to loss in Q2

    CVS Health slipped to a loss in the second quarter from a profit last year, hurt by certain goodwill impairment charges related to the Long-Term Care business. However, revenue and net loss for the quarter exceeded analysts’ expectations. Shares of the pharmacy benefits manager rose 2.24% during...
  2. Earnings Preview: CVS Health could turn active in Q2

    CVS Health is expected to post earnings for the second quarter on Wednesday before the market opens. Analysts expect the company to report upbeat results for the quarter. Investors remained concerned on the slowing revenue growth and the exuberant Aetna deal, which is predicted to close by...
  3. Carl Icahn opposes planned merger of Cigna and Express Scripts

    Billionaire activist investor Carl Icahn has taken a sizable stake in health insurer Cigna (CI) and plans to vote against the proposed merger of Cigna with Express Scripts (ESRX), thereby threatening to scupper the entire deal...
  4. Humana beats on Medicare Advantage plans

    Health insurer Humana (HUM) today reported its second-quarter earnings that surpassed analysts’ forecast, mainly due to surge in enrollment in the company’s Medicare Advantage plans. https://news.alphastreet.com/humana-earnings-q2-2018/
  5. Retail pharmacy lifts CVS Health in the first quarter

    CVS Health reported an increase of 2.6% in revenues to around $45.7 billion for the first quarter of 2018 compared to the prior year period. Net income rose 4.7% to $998 million or $0.98 per share. Adjusted EPS came in at $1.48, beating market estimates. The quarterly results benefited from...
  6. Top 5 US health insurers perfromance

    At a time when the US health insurance sector stares at a rise in premium prices, amid the government’s move to repeal the Individual Mandate clause, an analysis shows that major players in the sector registered consistent revenue growth over the past ten years. $ANTM $UNH $AET $HUM $CI Take a...
  7. CVS Health to acquire Aetna Inc

    $CVS has agreed to acquire $AET for approx. $207 per share or approx. $69Bil. Including the assumption of $AET debt, the total value of the deal is $77Bil. The transaction is expected to close in the second half of 2018. http://alph.st/bf21af3f